| Azithromycin has been proposed as a drug to treat COVID-19 infection, although this drug has torsadogenic potential which is cause for concern, especially if concomitantly administered with hydroxychloroquine/chloroquine |
| There is currently no evidence to support the efficacy of azithromycin treatment in COVID-19 infection, as completed trials are methodologically flawed and underpowered |
| Major public health organisations, drug regulatory agencies and scientific societies do not recommend the use of azithromycin as a drug to treat COVID-19 infection, unless bacterial superinfections occur |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.